Interestingly, CHMP2B knockout mice did not present with neurodegenerative phenotypes implicating a predominant toxic gain-of-function mechanism in CHMP2B-associated ALS and FTD [368]. This evidence concerns the gene CHMP2B and frontotemporal dementia.